Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase III results for trelagliptin, an oral, once-weekly DPP IV inhibitor

July 10, 2014

Researchers present results for BP-C1 in patients with stage IV breast cancer

July 10, 2014

Peroxynitrite decomposing catalyst has antidiabetic effects

July 10, 2014

Promising phase II and III results for a number of novel oncolytics presented at ASCO

July 9, 2014

Novel lipidated NMU analogues with promise for suppressing food intake in vivo

July 9, 2014

Once-daily tofacitinib shows bioequivalence for the immediate-release formulation

July 9, 2014

Promising phase I data presented for a number of oncolytic immunotherapy candidates

July 8, 2014

Early clinical results presented for PEX-168

July 8, 2014

MRZ-9547 assessed in Parkinson's disease models, enters phase I in healthy subjects

July 8, 2014

Researchers present a novel insulin analogue with improved glycemic control

July 8, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...